title: Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis.
abstract: Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated in uncontrolled diabetics. Intravitreal steroid delivers a localized dose in such situations. This case report highlights the efficacy of reduced dose of intravitreal triamcinolone acetonide (2 mg) in the treatment of active SC.
authors.affiliation: Department of Uvea, Aditya Birla Sankara Nethralaya, Kolkata, West Bengal, India.
authors.forename: Avirupa
authors.initials: A
authors.lastname: Ghose
authors.affiliation: Department of Uvea, Vision Research Foundation, Sankara Nethralayai, Chennai, Tamil Nadu, India.
authors.forename: Promod S
authors.initials: PS
authors.lastname: Bhende
authors.affiliation: Department of Uvea, Vision Research Foundation, Sankara Nethralayai, Chennai, Tamil Nadu, India.
authors.forename: Jyotirmoy
authors.initials: J
authors.lastname: Biswas
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D002833:Choroiditis / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007429:Intraocular Pressure; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014792:Visual Acuity
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014222:Triamcinolone Acetonide; D001379:Azathioprine